Streetbeat News

Products Services

ADTN

Adtran has opened a new Terafactory in Meiningen, Germany, to strengthen its supply chain resilience and accelerate regional technological advancements. The facility, backed by the Thuringian government, aims to create local jobs and reduce resource consumption through advanced automation technologies. The move mirrors Adtran's strategy in the US, where it recently expanded its manufacturing facility in Huntsville, Alabama. The Terafactory will reduce Adtran's dependence on overseas suppliers and stabilize the delivery of its networking solutions.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 1:22 pm

DXR

Daxor Corporation (NASDAQ:DXR), a global leader in blood volume measurement technology, has been granted a new patent for a system that provides remote blood volume monitoring. The patent covers various methods, including wearable devices like smartwatches. The technology will help optimize ongoing care based on the patient's evolving blood volume status. This addition to Daxor's intellectual property portfolio is part of the company's strategy to fuel future product development.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 1:20 pm

ESTA

Establishment Labs Holdings Inc. (NASDAQ:ESTA) has received approval from China's National Medical Products Administration for its Motiva Implants. This marks the company's entry into the second largest global market for breast aesthetics. The approval is the first for breast implant technology in China in over a decade. The company expects Chinese plastic surgeons to adopt their technology as their first choice.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 1:16 pm

AMZN

Amazon has announced the expansion of its Amazon Fresh grocery delivery and pickup service to all customers in the U.S., previously only available to Prime members. The company also plans to offer delivery from local grocery and specialty retailers, including Bristol Farms, Cardenas Markets, Pet Food Express, Weis Markets, and Save Mart. Amazon will also expand its grocery delivery and free pickup from Whole Foods Market to customers without a Prime membership. The company is also introducing re-imagined Amazon Fresh stores in Los Angeles, offering over 2,000 new national and private-label brand products, a Krispy Kreme Doughnut shop, and more.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 1:14 pm

AMT

BLZE

Backblaze, Inc. (NASDAQ:BLZE) is leveraging CoreSite's colocation and connectivity solutions to expand its cloud storage services in the eastern U.S. data region. CoreSite, a subsidiary of American Tower Corporation (NYSE:AMT), provides Backblaze with geographic diversity and an exabyte of capacity to support growing customer needs. The partnership also allows Backblaze customers to replicate their data from hyperscale cloud providers, including AWS and its Amazon S3 platform, to the Backblaze platform without egress fees.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 1:13 pm

NVDA

RXRX

Recursion (NASDAQ:RXRX) has announced a data collaboration deal with Tempus Labs, an ambition to build a top 50 supercomputer powered by NVIDIA (NASDAQ:NVDA), and an updated focus of collaboration with Bayer in precision oncology. Recursion will pay Tempus up to $160M over the next five years for access to one of the world's largest proprietary oncology datasets. The company also plans to quadruple its supercomputing power with NVIDIA's support. Additionally, Recursion and Bayer will initiate up to seven oncology programs, with Recursion eligible to receive up to $1.5 billion plus royalties on net sales.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 1:12 pm

KTTA

Pasithea Therapeutics Corp. (NASDAQ:KTTA) has selected a lead therapeutic candidate for its PAS-003 program, a humanized monoclonal antibody that targets α5β1 integrin, a protein found to be overexpressed in both human and mouse subjects with amyotrophic lateral sclerosis (ALS). The company has performed extensive mAb screening and characterization to enable selection of a lead therapeutic candidate with optimal properties for the treatment of ALS. The humanized lead candidate is a potent inhibitor of the primary ligand fibronectin (FN), has been optimized for high affinity and has high (sub-nanomolar) specificity with contact sites directly adjacent to the FN binding site documented by cryogenic electron microscopy (cryo-EM).

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 1:11 pm

ATRA

Atara Biotherapeutics, Inc. (NASDAQ:ATRA) shares dropped after the company announced that its Phase 2 EMBOLD study of ATA188 in non-active progressive multiple sclerosis (PMS) did not meet the primary endpoint. The company is reviewing the data and plans to reduce expenses on ATA188, focusing more on its allogeneic CAR-T pipeline and the expanded tab-cel partnership with Pierre Fabre. This strategy is expected to extend the cash runway beyond Q3 of 2025.

Portfolio Pulse from Nabaparna Bhattacharya

November 09, 2023 | 1:09 pm

MYNZ

Mainz Biomed has partnered with Liquid Biosciences to extend the use of EMERGE in its product development pipeline. This includes analysis of its eAArly DETECT study and the forthcoming U.S. pivotal FDA PMA trial (ReconAAsense). If successful, this will allow Mainz Biomed to advance its current test's capabilities and commercialize a next-generation colorectal cancer screening tool. The eAArly DETECT clinical trial is enrolling 265 subjects across 22 sites and is expected to report results in Q4 2023.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 1:07 pm

IMMP

Immutep has completed enrollment in its TACTI-003 Phase IIb trial of Efti and KEYTRUDA for first line metastatic or recurrent head and neck squamous cell carcinoma. The trial is a significant step in the development of these drugs.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 1:02 pm